Dr. Alejandro Marín-Menéndez
His main research interest is finding novel alternatives to current medicines to treat human infectious diseases. He has studied and worked in some of the most prestigious Universities and Research Centers of 8 different countries across the world. Among other experiences, he has played an active role in two European Consortiums (DNA-TRAP and NAREB) devoted to the fascinating field of nanoparticle development for drug delivery and in a Global Consortium studying the Epidemiology of malaria in pregnant women (PregVax).
At the moment, he is investigating a rare polymorphism that might be associated to natural resistance to malaria infections at both the Wellcome Sanger Institute in Cambridge and the Kenyan Medical Research Institute-Kilifi where he has engaged in several training and public engagement initiatives. Aiming to train new generations of promising students he has been registered as a STEM Ambassador and joined an International Mentors Program, IMFAHE, to promote excellent science education among undergraduate students.